|
Company
Name |
Short
Summary |
Afraxis |
Afraxis is focused on the research and development of drugs to treat diseases of the central nervous system. |
Agilent Technologies |
Agilent
Technologies is a global, diversified technology
company focusing on high-growth markets in the communications,
electronics, life sciences and healthcare industries. |
Ambrx |
Ambrx is engineering proteins with new amino acid building blocks beyond the common twenty, resulting in proteins with new physical, chemical and pharmacological properties.. |
Auspex Pharmaceuticals |
Auspex Pharmacueticals is focused on substitution deuterium for hydrogen within known active molecules to create superior drug candidates with alterted therapeutic profiles. |
BioWa |
BioWa is focused on research and development of fucose-free monoclonal antibodies that demonstrate increased antibody-dependent cellular cytotoxicity (ADCC). |
Carolus Therapeutics |
Carolus Therapeutics is focused on the development drugs to treat disorders triggered by acute and chronic inflammation. |
DermTech International |
DermTech International is focused on the development and validation of molecular tests using specimens derived from the skin. |
Johnson
& Johnson |
Johnson
& Johnson manufactures a broad range of products
in the health care field. Their business is divided
into three segments: Consumer, Pharmaceutical
and Professional. |
Ligand
Pharmaceuticals |
Ligand
Pharmaceuticals discovers, develops and markets
new drugs in the areas of cancer, skin diseases,
and men's and women's hormone related diseases,
as well as osteoporosis, metabolic disorders and
cardiovascular and inflammatory diseases. |
MediciNova |
MediciNova is focused on the acquisition and development of small-molecule therapeutics for a treatment of a variety of diseases. MediciNova primarily acquires the rights to these products by in-licensing from mid-sized Japanese pharmaceutical companies. |
Monsanto |
Monsanto produces leading seed brands in large-acre crops like corn, cotton, and oilseeds (soybeans and canola), as well as small-acre crops like vegetables. They also produce leading in-the-seed trait technologies for farmers that are aimed at protecting their yield, supporting their on-farm efficiency and reducing their on-farm costs. |
Multimeric Biotherapeutics |
Multimeric Biotherapeutics is focused on the research and development of a 2-trimer form of CD40 ligand (CD40L), |
Orexigen Therapeutics |
Orexigen Therapeutics is focused on the development of small molecule drugs for the treatment of obesity. |
Organogenesis |
Organogenesis
Inc. designs, develops and manufactures medical
products containing living cells and/or natural
connective tissue.
|
Pacira Pharmaceuticals |
Pacira Pharmaceuticals is focused on the research, development, and commercialization of products based on its proprietary DepoFoam® drug delivery technology with a focus in the post-surgical pain market. |
Pfizer |
Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. |
Protein Polymer Technologies |
Protein Polymer Technologies is focused on the development and commercialization of products which aid the natural process of bodily repair. |
Sophiris Bio |
Sophiris Bio is focused on the research and development of treatments for patients with benign prostatic hyperplasia (BPH). |